Effect of N-3 polyunsaturated fatty acid supplementation in pregnancy: The nuheal trial

T. Decsi, Cristina Campoy, Berthold Koletzko

Research output: Contribution to journalArticle

37 Citations (Scopus)

Abstract

In this placebo controlled, randomised, double blind trial, pregnant women received from the 20th week of gestation onwards either 500 mg docosahexaenoic acid (DHA), 400 mg 5-methyl-tetra-hydro-folate (5-MTHF), or placebo, or a combination of 500 mg DHA and 400 mg 5-MTHF. The dietary supplements were well tolerated; the dropout rates did not differ significantly in the active arms of the study (10% to 19%) from that seen in the placebo group (13%). DHA supplementation resulted in significant enhancement of the contribution of DHA to maternal, placental and venous cord blood lipids.

Original languageEnglish
Pages (from-to)109-113
Number of pages5
JournalAdvances in Experimental Medicine and Biology
Volume569
DOIs
Publication statusPublished - 2005

Fingerprint

Docosahexaenoic Acids
Omega-3 Fatty Acids
Pregnancy
Placebos
Folic Acid
Dietary supplements
Dietary Supplements
Fetal Blood
Pregnant Women
Blood
Mothers
Lipids

Keywords

  • Docosahexaenoic acid
  • Fetal nutrition
  • Long-chain polyunsaturated fatty acid
  • Methyl-tetra-hydro-folate
  • Pregnancy

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Effect of N-3 polyunsaturated fatty acid supplementation in pregnancy : The nuheal trial. / Decsi, T.; Campoy, Cristina; Koletzko, Berthold.

In: Advances in Experimental Medicine and Biology, Vol. 569, 2005, p. 109-113.

Research output: Contribution to journalArticle

@article{79e28f2bbd8148a6998b422e1f3b2e99,
title = "Effect of N-3 polyunsaturated fatty acid supplementation in pregnancy: The nuheal trial",
abstract = "In this placebo controlled, randomised, double blind trial, pregnant women received from the 20th week of gestation onwards either 500 mg docosahexaenoic acid (DHA), 400 mg 5-methyl-tetra-hydro-folate (5-MTHF), or placebo, or a combination of 500 mg DHA and 400 mg 5-MTHF. The dietary supplements were well tolerated; the dropout rates did not differ significantly in the active arms of the study (10{\%} to 19{\%}) from that seen in the placebo group (13{\%}). DHA supplementation resulted in significant enhancement of the contribution of DHA to maternal, placental and venous cord blood lipids.",
keywords = "Docosahexaenoic acid, Fetal nutrition, Long-chain polyunsaturated fatty acid, Methyl-tetra-hydro-folate, Pregnancy",
author = "T. Decsi and Cristina Campoy and Berthold Koletzko",
year = "2005",
doi = "10.1007/1-4020-3535-7_15",
language = "English",
volume = "569",
pages = "109--113",
journal = "Advances in Experimental Medicine and Biology",
issn = "0065-2598",
publisher = "Springer New York",

}

TY - JOUR

T1 - Effect of N-3 polyunsaturated fatty acid supplementation in pregnancy

T2 - The nuheal trial

AU - Decsi, T.

AU - Campoy, Cristina

AU - Koletzko, Berthold

PY - 2005

Y1 - 2005

N2 - In this placebo controlled, randomised, double blind trial, pregnant women received from the 20th week of gestation onwards either 500 mg docosahexaenoic acid (DHA), 400 mg 5-methyl-tetra-hydro-folate (5-MTHF), or placebo, or a combination of 500 mg DHA and 400 mg 5-MTHF. The dietary supplements were well tolerated; the dropout rates did not differ significantly in the active arms of the study (10% to 19%) from that seen in the placebo group (13%). DHA supplementation resulted in significant enhancement of the contribution of DHA to maternal, placental and venous cord blood lipids.

AB - In this placebo controlled, randomised, double blind trial, pregnant women received from the 20th week of gestation onwards either 500 mg docosahexaenoic acid (DHA), 400 mg 5-methyl-tetra-hydro-folate (5-MTHF), or placebo, or a combination of 500 mg DHA and 400 mg 5-MTHF. The dietary supplements were well tolerated; the dropout rates did not differ significantly in the active arms of the study (10% to 19%) from that seen in the placebo group (13%). DHA supplementation resulted in significant enhancement of the contribution of DHA to maternal, placental and venous cord blood lipids.

KW - Docosahexaenoic acid

KW - Fetal nutrition

KW - Long-chain polyunsaturated fatty acid

KW - Methyl-tetra-hydro-folate

KW - Pregnancy

UR - http://www.scopus.com/inward/record.url?scp=33644688056&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33644688056&partnerID=8YFLogxK

U2 - 10.1007/1-4020-3535-7_15

DO - 10.1007/1-4020-3535-7_15

M3 - Article

C2 - 16137113

AN - SCOPUS:33644688056

VL - 569

SP - 109

EP - 113

JO - Advances in Experimental Medicine and Biology

JF - Advances in Experimental Medicine and Biology

SN - 0065-2598

ER -